跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,992 条关于
“macular oedema”
全部
11,992
临床试验
10,736
药物
185
机构
53
资讯
1,018
3个月前
EMA Recommends Approval for Ranibizumab Biosimilar Vislyfa, Expanding European Treatment Options for Retinal Diseases
去年
Sandoz's Aflibercept Biosimilar Afqlir Gains European Commission Approval
去年
European Commission Approves Sandoz's Afqlir® (aflibercept) Biosimilar for Retinal Diseases
去年
European Commission Approves Sandoz's Afqlir, an Aflibercept Biosimilar, for Retinal Diseases
去年
Sandoz's Afqlir (Aflibercept) Biosimilar Approved in Europe for Retinal Diseases
9个月前
Biocon Biologics Secures Global Settlement for Aflibercept Biosimilar, Enabling Worldwide Commercialization
9个月前
Samsung Bioepis Secures European Approval for BYOOVIZ Pre-filled Syringe Formulation
去年
EMA's CHMP Recommends Approval of Six New Biosimilars
上个月
Trispecific Antibodies: The Next Frontier in Immunotherapy Gains Momentum with Big Pharma Investments
去年
Exonate Advances EXN407 Eye Drop to Phase IIb Trial for Diabetic Retinopathy Treatment
第 1 页,共 102 页
上一页
下一页